Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms

被引:0
|
作者
Mohammed S. Ellulu
机构
[1] Universiti Putra Malaysia (UPM),Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences
[2] Clinical Nutrition Specialist,undefined
来源
Inflammopharmacology | 2017年 / 25卷
关键词
Obesity; Cardiovascular disease; Metabolic syndrome; Inflammation; Oxidative stress; Thrombosis; Nitric oxide; Antioxidant; Vitamin C; Ascorbic acid;
D O I
暂无
中图分类号
学科分类号
摘要
Obesity means the accumulation of excessive fat that may interfere with the maintenance of optimal state of health. Obesity causes cardiac and vascular disease through well-known mediators such as hypertension, type-2 diabetes mellitus, and dyslipidemia, but there are evidences for other mediators such as chronic inflammation, oxidative stress, and thrombosis. The decreased levels of antioxidants factors and nitric oxide predispose to further cardiovascular adverse events. To reduce the risks, antioxidants can help by neutralizing the free radicals and protecting from damage by donating electrons. Having the capacity, vitamin C protects from oxidative stress, prevention of non-enzymatic glycosylation of proteins, and enhances arterial dilation through its effect on nitric oxide release. It also decreases lipid peroxidation, and alleviates inflammation. The anti-inflammatory property of vitamin C could be attributed to ability to modulate the NF-kB DNA binding activity and down-regulation in the hepatic mRNA expression for the interleukins and tumor factors.
引用
收藏
页码:313 / 328
页数:15
相关论文
共 50 条
  • [1] Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms
    Ellulu, Mohammed S.
    INFLAMMOPHARMACOLOGY, 2017, 25 (03) : 313 - 328
  • [2] Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
    Khafagy, Rana
    Dash, Satya
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [3] Targets of Vitamin C With Therapeutic Potential for Cardiovascular Disease and Underlying Mechanisms: A Study of Network Pharmacology
    Zhu, Ning
    Huang, Bingwu
    Jiang, Wenbing
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [4] Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
    Mason, Justin C.
    Libby, Peter
    EUROPEAN HEART JOURNAL, 2015, 36 (08) : 482 - U102
  • [5] Is there a role for vitamin C in preventing osteoporosis and fractures? A review of the potential underlying mechanisms and current epidemiological evidence
    Finck, Henriette
    Hart, Andrew R.
    Jennings, Amy
    Welch, Ailsa A.
    NUTRITION RESEARCH REVIEWS, 2014, 27 (02) : 268 - 283
  • [6] Inflammation and cardiovascular disease mechanisms
    Libby, P
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (02): : 456S - 460S
  • [7] VITAMIN-C AND CARDIOVASCULAR-DISEASE - A REVIEW
    SIMON, JA
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1992, 11 (02) : 107 - 125
  • [8] Inflammation, sleep, obesity and cardiovascular disease
    Miller, Michelle A.
    Cappuccio, Francesco P.
    CURRENT VASCULAR PHARMACOLOGY, 2007, 5 (02) : 93 - 102
  • [9] The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review
    Pivonello, Claudia
    Negri, Mariarosaria
    Patalano, Roberta
    Amatrudo, Feliciana
    Monto, Tatiana
    Liccardi, Alessia
    Graziadio, Chiara
    Muscogiuri, Giovanna
    Pivonello, Rosario
    Colao, Annamaria
    OBESITY REVIEWS, 2022, 23 (03)
  • [10] Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms
    Verges, Bruno
    DIABETES & METABOLISM, 2020, 46 (06) : 442 - 449